Literature DB >> 16043427

Determination of metformin in human plasma by high-performance liquid chromatography.

Hossein Amini1, Abolhassan Ahmadiani, Parisa Gazerani.   

Abstract

A simple, selective and sensitive high-performance liquid chromatographic method with spectrophotometric detection was developed for the determination of antihyperglycemic agent metformin in human plasma using a novel sample extraction procedure. Liquid-liquid extraction of metformin and ranitidine (as internal standard) from plasma samples was performed with 1-butanol/n-hexane (50:50, v/v) in alkaline condition followed by back-extraction into diluted acetic acid. Chromatography was carried out using a silica column (250 mmx4.6 mm, 5 microm) under isocratic elution with acetonitrile-40 mM aqueous sodium dihydrogen phosphate (25:75, v/v), pH 6. The limit of quantification (LOQ) was 15.6 ng/ml and the calibration curves were linear up to 2000 ng/ml. The mean absolute recoveries for metformin and internal standard using the present extraction procedure were 98 and 95%, respectively. The intra- and inter-day coefficient of variation and percent error values of the assay method were all less than 8.3%.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043427     DOI: 10.1016/j.jchromb.2005.07.009

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus.

Authors:  Christophe Bardin; Estelle Nobecourt; Etienne Larger; François Chast; Jean-Marc Treluyer; Saik Urien
Journal:  Eur J Clin Pharmacol       Date:  2012-01-25       Impact factor: 2.953

2.  A supercritical fluid chromatography/tandem mass spectrometry method for the simultaneous quantification of metformin and gliclazide in human plasma.

Authors:  Y K Agrawal; P J Gogoi; K Manna; H G Bhatt; V K Jain
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

3.  Stability-indicating HPTLC method for simultaneous determination of nateglinide and metformin hydrochloride in pharmaceutical dosage form.

Authors:  Asha Byju Thomas; Shrikrushna Digambar Patil; Rabindra Kumar Nanda; Lata Prasad Kothapalli; Shital Shridhar Bhosle; Avinash Devidas Deshpande
Journal:  Saudi Pharm J       Date:  2011-07-05       Impact factor: 4.330

4.  Rapid and Simple RPHPLC Method for the Estimation of Metformin in Rat Plasma.

Authors:  M M Wanjari; A W There; M R Tajne; C T Chopde; S N Umathe
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

5.  The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.

Authors:  J Jeyabalan; B Viollet; P Smitham; S A Ellis; G Zaman; C Bardin; A Goodship; J P Roux; M Pierre; C Chenu
Journal:  Osteoporos Int       Date:  2013-05-04       Impact factor: 4.507

Review 6.  Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions.

Authors:  Melissa Jones; Corina Mihaela Ionescu; Daniel Walker; Susbin Raj Wagle; Bozica Kovacevic; Jacqueline Chester; Thomas Foster; Edan Johnston; Jafri Kuthubutheen; Daniel Brown; Marcus D Atlas; Momir Mikov; Armin Mooranian; Hani Al-Salami
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.